Coeptis Therapeutics, Inc. (COEP)
USD 0.18
(-16.07%)
USD 0.18
(-16.07%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -20.15 Million USD | 37.84% |
| 2022 | -36.35 Million USD | -157.25% |
| 2021 | -12.81 Million USD | -47.53% |
| 2020 | -8.68 Million USD | -5153.34% |
| 2019 | 171.86 Thousand USD | 0.0% |
| 2005 | -344.3 Thousand USD | -113.0% |
| 2004 | 2.64 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -2.57 Million USD | -6.6% |
| 2024 Q1 | -2.67 Million USD | 26.94% |
| 2023 Q2 | -3.34 Million USD | 46.04% |
| 2023 Q1 | -6.19 Million USD | -133.9% |
| 2023 FY | - USD | 37.84% |
| 2023 Q4 | -3.11 Million USD | 59.0% |
| 2023 Q3 | -7.59 Million USD | -127.2% |
| 2022 Q4 | -2.65 Million USD | 50.39% |
| 2022 Q3 | -5.34 Million USD | 43.79% |
| 2022 Q2 | -9.5 Million USD | 38.55% |
| 2022 Q1 | -15.46 Million USD | -525.44% |
| 2022 FY | - USD | -157.25% |
| 2021 Q3 | -5.75 Million USD | -109.5% |
| 2021 FY | - USD | -47.53% |
| 2021 Q1 | -1.91 Million USD | -292.9% |
| 2021 Q2 | -2.74 Million USD | -43.47% |
| 2021 Q4 | -2.47 Million USD | 57.04% |
| 2020 FY | - USD | -5153.34% |
| 2020 Q4 | -487.36 Thousand USD | -3922.83% |
| 2020 Q3 | -12.11 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2005 FY | - USD | -113.0% |
| 2005 Q1 | -32.00 USD | 0.0% |
| 2005 Q2 | -174.07 Thousand USD | -543896.88% |
| 2005 Q4 | -134.22 Thousand USD | -1443.54% |
| 2005 Q3 | -8696.00 USD | 95.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | -100.0% |
| 2004 Q3 | 2.64 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 71.623% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -239.989% |
| SQZ Biotechnologies Company | -64.14 Million USD | 68.573% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -16.048% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 121.436% |
| Mesoblast Limited | -62.38 Million USD | 67.691% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -1212.303% |
| Genus plc | 73.7 Million USD | 127.351% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -204.886% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -468.301% |
| Marizyme, Inc. | -34.28 Million USD | 41.2% |
| ContraFect Corporation | -64.99 Million USD | 68.988% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -129.795% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -345.355% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -1337.973% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -662.262% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -767.435% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -3791.087% |
| Accustem Sciences Inc. | -3.74 Million USD | -438.05% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 58.203% |
| EV Biologics, Inc. | -1.26 Million USD | -1490.806% |
| Q BioMed Inc. | -617.62 Thousand USD | -3163.715% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 664.323% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -3087.449% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -782.369% |
| Biomind Labs Inc. | -1.03 Million USD | -1848.445% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 304.086% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -181.481% |
| Skye Bioscience, Inc. | -13.54 Million USD | -48.792% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -1255.214% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -80530.472% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -418.948% |
| IMV Inc. | -35.52 Million USD | 43.255% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -27.019% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -705.672% |
| GB Sciences, Inc. | -1.41 Million USD | -1319.666% |
| Alpha Cognition Inc. | -9.7 Million USD | -107.691% |
| HST Global, Inc. | -5303.00 USD | -380017.254% |
| CSL Limited | 4.78 Billion USD | 100.421% |
| Halberd Corporation | -74.27 Thousand USD | -27037.708% |
| Enzolytics Inc. | -2.12 Million USD | -849.922% |
| Resverlogix Corp. | -11.74 Million USD | -71.671% |
| Affymax, Inc. | -14.29 Million USD | -41.012% |
| SYBLEU INC | -141.57 Thousand USD | -14138.522% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -558.097% |
| argenx SE | -216.02 Million USD | 90.669% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 63.574% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 1756.337% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -1244.822% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 5420.823% |
| AVAX Technologies, Inc. | -6.11 Million USD | -229.769% |
| Zenith Capital Corp. | -8.6 Million USD | -134.227% |
| Genscript Biotech Corporation | -248.71 Million USD | 91.895% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -115608.731% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -723.95% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -11351.607% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 49.144% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -596.935% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -1826.54% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 299886.109% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -1051.865% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -949.378% |
| BioStem Technologies, Inc. | -7.55 Million USD | -166.859% |
| ONE Bio Corp. | 13.61 Million USD | 248.076% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -11031.394% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -879.952% |
| Agentix Corp. | -1.37 Million USD | -1369.475% |
| LadRx Corporation | 412.28 Thousand USD | 4989.267% |
| Cell Source, Inc. | -4.27 Million USD | -371.796% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -5389.233% |
| Regen BioPharma, Inc. | 1.46 Million USD | 1475.049% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -2051.41% |
| NovAccess Global Inc. | -1.03 Million USD | -1847.978% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 327.672% |
| Itoco Inc. | -1.86 Million USD | -978.527% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -5209.946% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -1706.238% |
| Kadimastem Ltd | -2.62 Million USD | -668.09% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -8328.86% |
| CytoDyn Inc. | -18.02 Million USD | -11.807% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -25406.609% |
| Mobile Lads Corp. | -2.24 Million USD | -799.428% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -164734.557% |
| Qrons Inc. | -40.08 Thousand USD | -50192.203% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -4050.408% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 3921.835% |
| Rebus Holdings, Inc. | -951 Thousand USD | -2019.623% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -1798.063% |
| International Stem Cell Corporation | 202 Thousand USD | 10079.019% |
| Bioxytran, Inc. | -3.82 Million USD | -427.666% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -38193.347% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -718.772% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 43.802% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -44694.707% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -636.217% |
| Neutra Corp. | -181.24 Thousand USD | -11021.628% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 0.007% |
| PureTech Health plc | -11.62 Million USD | -73.369% |
| IXICO plc | -707 Thousand USD | -2751.148% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -162.298% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 58.306% |
| CSL Limited | 4.73 Billion USD | 100.426% |
| Cellectis S.A. | -92.63 Million USD | 78.24% |